Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 8/20 | 0.40 |
| ▸ | FAAH | O00519 | 7/20 | 0.40 |
| ▸ | CES2 | O00748 | 3/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3873600 | 1.00 | TP53 (0.46) | TP53EPHX1MAPTCES1FAAH | |
| SCHEMBL28887913 | 0.98 | TP53 (0.47) | TP53EPHX1MAPTCES1FAAH | |
| SCHEMBL575574 | 0.93 | TP53 (0.47) | TP53EPHX1MAPTCES1FAAH | |
| 1,3-Propanediol SCHEMBL575643 | 0.93 | TP53 (0.43) | TP53EPHX1MAPTCES1FAAH | |
| 1,4-Butanediol SCHEMBL576085 | 0.93 | TP53 (0.43) | TP53EPHX1MAPTCES1FAAH | |
| SCHEMBL4344566 | 0.92 | TP53 (0.39) | TP53EPHX1CES1FAAHCES2 | |
| Propylene Glycol SCHEMBL575859 | 0.88 | TP53 (0.43) | TP53EPHX1MAPTCES1GPR84 | |
| Hydroquinone SCHEMBL575698 | 0.87 | TRPV1 (0.40) | TP53MAPTMEN1KMT2AHSD17B10 | |
| SCHEMBL575945 | 0.87 | TP53 (0.39) | TP53EPHX1MAPTGPR84MEN1 | |
| 1,3-Butanediol SCHEMBL575626 | 0.85 | TP53 (0.45) | TP53EPHX1CES1GPR84FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080009655-A1 | Production Processes and Systems, Compositions, Surfactants, Monomer Units, Metal Complexes, Phosphate Esters, Glycols, Aqueous Film Forming Foams, and Foam Stabilizers | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009655-A1 | Production Processes and Systems, Compositions, Surfactants, Monomer Units, Metal Complexes, Phosphate Esters, Glycols, Aqueous Film Forming Foams, and Foam Stabilizers | FOS, AFF4, AFF1 | TP53 460/4885EPHX1 2353/4885MAPT 221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.